Generational Shift From Tech To Defensive Stocks

10 min read
0 views
Nov 17, 2026

Investors are dumping high-flying tech names at the fastest pace in a generation and rushing into boring defensive stocks. The performance gap is the widest since 2001. What comes next could reshape entire portfolios...

Financial market analysis from 17/11/2026. Market conditions may have changed since publication.

I’ve been watching the market long enough to know when something feels different. Lately the air has changed. After years of chasing the next artificial intelligence winner, a growing number of investors are quietly stepping away from the high-flying tech names and heading toward the steady, almost forgotten corners of the market. We’re talking about the biggest rotation into defensive stocks in roughly twenty-five years. That kind of move doesn’t happen every quarter. When it does, it usually leaves a mark that lasts much longer than a single earnings season.

Why Investors Are Suddenly Loving Boring Stocks Again

Since the start of October the consumer staples, healthcare and utilities groups have climbed an average of about thirteen percent. At the same time the Nasdaq 100, which leans heavily toward technology, has slipped roughly the same amount. The twenty-six percentage point gap is the widest we have seen since the autumn of 2001, right after the first big tech bubble deflated. I’ve found that numbers like these tend to grab attention, yet the real story sits underneath the percentages.

People are tired of the roller coaster. Debt levels tied to massive data-center builds have started to raise eyebrows. Political shifts after the midterm elections added another layer of caution. And then came the high-profile controversy surrounding a major chipmaker’s chief executive. Put those pieces together and you get a market that suddenly prefers companies selling tissues, beer, prescription drugs and everyday groceries over the latest artificial intelligence promise.

In my experience, rotations of this size rarely reverse overnight. They tend to gather momentum as more portfolio managers look at their own exposure and decide the risk-reward no longer favors pure growth. That is exactly the environment we are navigating right now.

The Consumer Staples Comeback Nobody Expected

Let’s start with the household names that used to sit quietly in the background. Kimberly-Clark is a perfect example. The company behind Huggies and Kleenex recently closed a large acquisition that brought well-known health brands under one roof. Everyday products that people buy whether the economy is roaring or limping. I started following the name more closely in early September because the deal felt like a genuine catalyst rather than a marketing slide.

The stock did not jump the moment the position was opened. In fact the first few weeks felt a little bumpy. That is when the real opportunity appeared. Adding on weakness lowered the average cost and left the holding better positioned for the months ahead. The market still seems to undervalue how effectively the new health brands can be integrated and grown. When a company sells products that never really go out of style, patience often pays.

Costco has been another quiet winner. The membership warehouse model continues to prove its strength year after year. Competitive pricing keeps customers loyal while the annual fee provides a predictable stream of income. Last week the board announced a sizable special dividend along with a fresh share-repurchase program. The market noticed. Shares climbed for five sessions in a row and now sit near record territory. Analysts recently lifted their targets after seeing strong October sales figures, citing everything from emergency preparedness shopping to steady everyday demand.

Constellation Brands rounds out the staples trio. The Corona and Modelo parent had been out of the portfolio for a stretch, then returned earlier this month. Beer sales can feel cyclical, yet the company still returns capital to shareholders and carries less volatility than many pure growth names. Recent comments from management suggest the consumer base is stabilizing after months of pressure. Buying on dips has been the preferred approach so far, and the position has already been added to once.


Healthcare Names That Keep Delivering

If one sector captures the defensive mood better than any other, it is healthcare. Johnson & Johnson feels like the textbook case. Shares briefly touched an all-time high this week after the company agreed to acquire a clinical-stage eye-care business for roughly three billion dollars. The deal expands an already deep pipeline of treatments for serious vision problems. In a market hungry for tangible growth that does not depend on the next artificial intelligence breakthrough, that kind of news lands well.

The position was started back in April. Despite a couple of soft days this week, the stock remains more than seventeen percent higher since then. A robust drug portfolio combined with selective bolt-on deals continues to attract investors who want both stability and a path to growth.

Cardinal Health has been even more dramatic. The distributor role in the healthcare supply chain rarely grabs headlines, yet the stock has behaved like a rocket since the spring. An early entry looked a little premature at first, but additional purchases during the soft patch turned out well. After a strong earnings report that included raised guidance, the price target was moved higher. Discipline still matters, so the position was trimmed twice on the way up simply to lock in gains after a parabolic run.

Eli Lilly remains the growth engine within the defensive group. Demand for its diabetes and obesity medicines shows little sign of slowing. A solid quarter featured continued traction for the new oral option, and regulatory clearance in China for that same product arrived as a welcome bonus. Shares have been nearly unstoppable since mid-September, which is why a portion of the position was sold near the recent high. Taking some profits does not mean abandoning the thesis. It simply keeps the overall portfolio balanced.

What Sparked the Rotation in the First Place

Several threads came together at once. Concerns about the sheer amount of capital being poured into artificial intelligence infrastructure have grown louder. Some of that spending is financed with debt, and markets eventually start asking harder questions about returns. The midterm election results shifted the political landscape in ways that made certain investors more cautious about growth-oriented sectors. Then came the high-profile personal controversy involving a leading chip executive. None of these events alone would have caused a full rotation, but together they tipped the scale.

I’ve noticed that once a narrative takes hold, it can feed on itself. Portfolio managers who feel overexposed to technology begin selling. That selling creates relative strength in the defensive names. More money follows the strength. Before long the gap between the two groups becomes too large to ignore. That is the stage we appear to be in right now.

After years of chasing the next big growth story, many investors simply want companies that keep selling the same products no matter what the economic headlines say.

How Portfolio Adjustments Were Made

The practical response was straightforward. Exposure to data-center related names was reduced. Positions in companies tightly linked to the artificial intelligence build-out were exited earlier in the autumn. At the same time capital was redirected into the staples and healthcare holdings already mentioned. The goal was never to abandon growth entirely. It was to lower overall volatility while still keeping a clear path to long-term returns.

Adding to winners on strength and adding to new names on weakness created a more resilient mix. Trimming the hottest names after sharp runs kept position sizes from becoming too large. None of these steps required predicting the exact bottom or top. They simply followed the flow of capital and the change in market preference.

Looking at Relative Performance More Closely

Relative strength charts tell part of the story. When defensive sectors begin outperforming the broader technology group by a wide margin, history suggests the trend can last longer than most people expect. The last time we saw a gap this large was during the post-bubble period more than two decades ago. Markets do not repeat exactly, yet they often rhyme. Investors who dismissed the earlier rotation as temporary eventually found themselves playing catch-up.

Utilities have participated as well, though the article focuses more on staples and healthcare because those are the areas where specific positions have been built. The common thread is predictable demand. People still need electricity, medicine, food and household products even when they delay buying the latest gadget.

Risks That Still Deserve Attention

No rotation is risk-free. If artificial intelligence spending accelerates again and produces clear returns, technology stocks could regain leadership quickly. Interest-rate moves can also shift preferences. A sudden drop in yields might breathe new life into growth names. Political developments remain fluid. Any of these factors could slow or reverse the current preference for defensive stocks.

That is why position sizes stay measured and why profits are taken along the way. The goal is participation in the trend without becoming overly concentrated in any single group. Diversification remains the quiet hero of this entire process.

Practical Lessons for Everyday Investors

Watch relative performance more than absolute numbers. When one group of stocks starts pulling away from another, pay attention. Avoid the temptation to sell everything that has worked for the past few years simply because something new is working. Instead, rebalance gradually. Use periods of weakness in high-quality defensive names as opportunities to build positions rather than moments of panic.

Keep an eye on balance sheets and capital return programs. Companies that can raise dividends, buy back shares or fund acquisitions without stretching their finances tend to hold up better when markets grow nervous. Costco’s recent special dividend is a textbook illustration of that strength.

  • Focus on businesses with steady demand regardless of economic cycles
  • Prefer companies that return capital through dividends or buybacks
  • Trim winners after parabolic moves to manage risk
  • Add to high-quality names when temporary weakness appears
  • Maintain overall portfolio balance rather than swinging fully from one extreme to another

The Longer-Term Picture Still Favors Quality

Even if technology regains some momentum later, the companies that sell essential products are unlikely to disappear. They generate cash, pay dividends and give investors something solid to hold during uncertain stretches. In my view that combination has lasting value. The current rotation simply reminds everyone that markets move in cycles and that no single style stays on top forever.

Perhaps the most interesting aspect is how quickly sentiment shifted. Only a few months ago the conversation was almost entirely about artificial intelligence winners. Now the same voices are talking about diapers, beer, eye treatments and warehouse clubs. Markets have a way of surprising even the most experienced observers.

Building a More Resilient Approach Going Forward

The practical takeaway is not to abandon growth forever. It is to make sure a portfolio can weather different environments. Holding a core group of defensive stocks alongside selective growth names creates that flexibility. When one group struggles, the other often helps offset the pressure. Over full market cycles that balance tends to produce smoother results and fewer sleepless nights.

I keep returning to the same simple idea. Own businesses that people need every day, manage position sizes carefully, and stay willing to adjust when the evidence changes. The current flight into defensive stocks is a clear signal that many investors are already following that path. Whether the trend lasts another month or another year, the underlying logic still holds.

Looking ahead, the next few earnings seasons will tell us more. Consumer spending data, healthcare pipeline updates and any fresh commentary on capital spending plans will either reinforce or challenge the rotation. Until those signals arrive, the preference for stability over pure speculation looks firmly in place. That is the environment we are navigating, and the portfolio has already been adjusted to reflect it.

Staying flexible remains the real edge. Markets rarely move in a straight line, and the companies that thrive across different conditions are usually the ones that keep delivering the products and services people rely on without fanfare. Right now those quieter names are finally getting the attention they deserve. The shift may feel sudden, yet the reasons behind it have been building for months. Investors who recognize the change early often find themselves better positioned for whatever comes next.

In the end the story is less about abandoning technology and more about restoring balance. Growth still has a place. So do the steady compounders that rarely make the loudest headlines. Blending the two has always been the more durable approach, and the current rotation is simply bringing that truth back into focus for a new generation of market participants.

The coming weeks will show whether the gap between defensive stocks and technology continues to widen or begins to narrow. Either way, the process of rebalancing toward greater stability has already started. For those who prefer to sleep a little better at night while still participating in long-term market gains, that process looks like a step in the right direction.

Watching capital flow from one corner of the market to another is a reminder that no leadership lasts forever. The names that dominated the past four years of artificial intelligence enthusiasm are now sharing the stage with companies that sell the basics of daily life. That sharing of the spotlight may prove healthier for portfolios than many people currently expect. Time will tell, yet the early evidence already points toward a more measured and diversified mindset taking hold across a wide range of investors.

That measured mindset is worth cultivating even after the current rotation eventually runs its course. Markets will always cycle between fear and greed, growth and value, excitement and caution. The investors who treat those cycles as opportunities to rebalance rather than reasons to panic tend to arrive at better long-term outcomes. The present move into defensive stocks is simply the latest chapter in that ongoing story.

❝
If investing is entertaining, if you're having fun, you're probably not making any money. Good investing is boring.
— George Soros
Author

Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.

Related Articles

?>